Equity
LABORATOIRES BAILLEUL has made a profit in every financial year since 2006.
LABORATOIRES BAILLEUL has made a profit in every financial year since 2006.
Green is investment, beige is depreciation. Machinery stands 231.6% higher than in 2024.
The dashed line is the sector median: < 0.1% across 1,080 companies (NACE 86, small).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 16% on liquidity, 15% on profitability and 57% on growth.
The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 14,766 companies had the same profile as LABORATOIRES BAILLEUL has now. Each dot stands for 37 companies, two years later.
Another 0.1% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of LABORATOIRES BAILLEUL itself: < 0.1% within 12 months.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,766 companies, not a prediction for LABORATOIRES BAILLEUL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is ample, with a current ratio of 4.13 (4.26 in 2024), above the usual 1.5. Short-term debt is 23.8% and cash 5.6% of total assets. 24% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 7 accounts on average 42 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| LABORATOIRES BAILLEUL Anderlecht | €6.7m | 3.1% | 76.0% | 12.8 |
| EasyNurse.be Grobbendonk | €3.1m | -17.7% | 7.8% | 17.9 |
| PLASMA PROTEIN THERAPEUTICS ASSOCIATION EUROPE Woluwe-Saint-Lambert | €3.4m | 2.8% | 50.4% | 8 |
| Experconsult Brussels | €2.5m | 9.3% | 81.7% | 5.2 |
| RELIANCE - L'ASSOCIATION REGIONALE DES SOINS PALLIATIFS DE MONS-BORINAGE - LA LOUVIERE - SOIGNIES La Louvière | €1.6m | 18.0% | 75.1% | 16.4 |
| Wijkgezondheidscentrum De Central Leuven | €1.5m | 13.8% | 67.5% | 16.9 |
| Centrum voor Ambulante Revalidatie D.A.T. Tienen | €2.0m | 2.0% | 76.2% | 24.5 |
Grey: the largest companies of the sector (human health (NACE 86)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as LABORATOIRES BAILLEUL: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €1.7m and €3.7m, founded between 1994 and 2005.
LABORATOIRES BAILLEUL has existed since 2002. Turnover grew from €3.1m in 2014 to €6.7m in 2025 and staff from 8 to 12.8 full-time equivalents.
Turnover has grown every year since 2022.
Laboratoires Bailleul International S. Etr. holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.